LOTTE BIOLOGICS’ Songdo Bio Campus, Incheon, South Korea
LOTTE BIOLOGICS’ Songdo Bio Campus in Incheon, South Korea includes the development of three biomanufacturing facilities by 2030.
Bristol-Myers Squibb Company
Discovery and Development of Biopharmaceuticals
Subscribed
You have successfully submitted your enquiry. Someone from our company will respond ASAP
About Us
Bristol-Myers Squibb is a biopharmaceutical company that carries out the discovery and development of transformational medicines for patients suffering from cancer (both solid tumors and hematology), immune disorders, cardiovascular, and neurological disorders. Its pharmaceutical products include small molecule drugs, products produced from biological processes called biologics, and chimeric antigen receptor (CAR) T-cell therapies. The company’s approved products include Revlimid, Eliquis, Opdivo, Pomalyst, Orencia, Sprycel, Yervoy, Abraxane, and Reblozyl, among others.
It concentrates on research and development efforts in disease areas with significant unmet medical needs such as cancer, including immuno-oncology (IO), haematology and cell therapy, including multiple myeloma, lymphoma, and chronic lymphocytic leukaemia, immune disorders including relapsing multiple sclerosis, psoriasis, lupus, rheumatoid arthritis and inflammatory bowel disease, cardiovascular, including cardiomyopathy, heart failure and thrombotic disorders, and fibrotic disease, specifically lung and liver. The company is optimistic about its recent acquisitions such as Celgene and MyoKardia to enhance its presence further in these areas.
Projects
Contact Details
Website
Email Address
Address
430 East, 29th Street
14th Floor,
New York,
United States of America
14th Floor,
New York,
United States of America
Phone
Regional Offices
Address
Bristol-Myers Squibb Company
430 East, 29th Street
14th Floor
New York
United States of America